Dr. Youssef Josephson, D.O
NPI: 1598928608
Total Payments
$783,511
2024 Payments
$33,017
Companies
74
Transactions
2,847
Medicare Patients
4,200
Medicare Billing
$640,487
Payment Breakdown by Category
Other$537,898 (68.7%)
Consulting$100,013 (12.8%)
Travel$83,530 (10.7%)
Food & Beverage$54,421 (6.9%)
Education$7,024 (0.9%)
Research$625.00 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $477,966 | 138 | 61.0% |
| Consulting Fee | $100,013 | 58 | 12.8% |
| Travel and Lodging | $83,530 | 255 | 10.7% |
| Food and Beverage | $54,421 | 2,321 | 6.9% |
| Compensation for serving as faculty or as a speaker for a medical education program | $33,264 | 25 | 4.2% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $26,331 | 18 | 3.4% |
| Education | $7,024 | 27 | 0.9% |
| Unspecified | $625.00 | 2 | 0.1% |
| Entertainment | $338.37 | 3 | 0.0% |
Payments by Type
General
$782,886
2,845 transactions
Research
$625.00
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic USA, Inc. | $178,883 | 366 | $0 (2020) |
| Vertiflex, Inc. | $173,240 | 217 | $0 (2019) |
| Abbott Laboratories | $156,868 | 682 | $0 (2024) |
| Boston Scientific Corporation | $123,096 | 195 | $0 (2024) |
| Jazz Pharmaceuticals Inc. | $31,389 | 49 | $0 (2018) |
| PAINTEQ LLC | $22,982 | 109 | $0 (2024) |
| PFIZER INC. | $19,847 | 58 | $0 (2021) |
| Depomed, Inc. | $16,349 | 35 | $0 (2017) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $10,916 | 128 | $0 (2024) |
| TerSera Therapeutics LLC | $7,297 | 35 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33,017 | 179 | Abbott Laboratories ($30,539) |
| 2023 | $29,827 | 209 | Abbott Laboratories ($26,665) |
| 2022 | $61,226 | 349 | Abbott Laboratories ($38,910) |
| 2021 | $90,390 | 350 | Boston Scientific Corporation ($65,257) |
| 2020 | $99,581 | 297 | Boston Scientific Corporation ($53,563) |
| 2019 | $163,027 | 496 | Vertiflex, Inc. ($98,432) |
| 2018 | $155,195 | 500 | Vertiflex, Inc. ($74,375) |
| 2017 | $151,249 | 467 | Medtronic USA, Inc. ($82,870) |
All Payment Transactions
2,847 individual payment records from CMS Open Payments — Page 1 of 114
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $137.72 | General |
| Category: Neuromodulation | ||||||
| 12/19/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $14.44 | General |
| Category: General - Pain Management_NMD | ||||||
| 12/18/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $19.20 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/18/2024 | TerSera Therapeutics LLC | Prialt (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Pain Management | ||||||
| 12/18/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $4.70 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/17/2024 | Currax Pharmaceuticals LLC | ONZETRA XSAIL (Drug) | Food and Beverage | In-kind items and services | $14.14 | General |
| Category: Neurology | ||||||
| 12/13/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.38 | General |
| Category: Opioid Analgesic | ||||||
| 12/13/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $12.01 | General |
| Category: Neuromodulation | ||||||
| 12/12/2024 | Abbott Laboratories | PROCLAIM (Device) | Travel and Lodging | In-kind items and services | $611.12 | General |
| Category: Neuromodulation | ||||||
| 12/11/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: Neuromodulation | ||||||
| 12/11/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $4.35 | General |
| Category: Neuromodulation | ||||||
| 11/27/2024 | Abbott Laboratories | PROCLAIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $630.00 | General |
| Category: Neuromodulation | ||||||
| 11/27/2024 | Abbott Laboratories | PROCLAIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $341.25 | General |
| Category: Neuromodulation | ||||||
| 11/27/2024 | Abbott Laboratories | PROCLAIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $315.00 | General |
| Category: Neuromodulation | ||||||
| 11/27/2024 | Abbott Laboratories | PROCLAIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $210.00 | General |
| Category: Neuromodulation | ||||||
| 11/27/2024 | Abbott Laboratories | PROCLAIM (Device) | Travel and Lodging | In-kind items and services | $142.04 | General |
| Category: Neuromodulation | ||||||
| 11/27/2024 | Abbott Laboratories | PROCLAIM (Device) | Travel and Lodging | In-kind items and services | $131.99 | General |
| Category: Neuromodulation | ||||||
| 11/27/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $63.44 | General |
| Category: Neuromodulation | ||||||
| 11/27/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $19.67 | General |
| Category: Neuromodulation | ||||||
| 11/27/2024 | Abbott Laboratories | PROCLAIM (Device) | Travel and Lodging | In-kind items and services | $13.50 | General |
| Category: Neuromodulation | ||||||
| 11/26/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $18.73 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/26/2024 | Nevro Corp. | Senza (Device) | Food and Beverage | In-kind items and services | $1.12 | General |
| Category: Spinal Cord Stimulator | ||||||
| 11/25/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $99.05 | General |
| Category: Neuromodulation | ||||||
| 11/25/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $76.63 | General |
| Category: Neuromodulation | ||||||
| 11/22/2024 | Abbott Laboratories | PROCLAIM (Device) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,920.00 | General |
| Category: Neuromodulation | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Secure Study | PAINTEQ LLC | $475.00 | 1 |
| SECURE Study | PAINTEQ LLC | $150.00 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 1,766 | 3,288 | $1.8M | $266,382 |
| 2022 | 15 | 706 | 1,295 | $1.2M | $107,960 |
| 2021 | 21 | 960 | 1,852 | $1.5M | $148,847 |
| 2020 | 24 | 768 | 1,344 | $1.5M | $117,298 |
Total Patients
4,200
Total Services
7,779
Medicare Billing
$640,487
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 286 | 735 | $209,375 | $73,542 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 362 | 782 | $143,700 | $52,441 | 36.5% |
| 0275T | Removal of bone from lower spine for decompression of nerve tissue using imaging guidance, accessed through the skin | Facility | 2023 | 20 | 20 | $76,548 | $14,518 | 19.0% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 53 | 57 | $126,450 | $12,001 | 9.5% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 75 | 80 | $79,200 | $11,663 | 14.7% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2023 | 18 | 42 | $110,275 | $9,143 | 8.3% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 95 | 117 | $111,000 | $8,692 | 7.8% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Facility | 2023 | 67 | 86 | $183,720 | $6,739 | 3.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 42 | 42 | $12,915 | $5,415 | 41.9% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Office | 2023 | 19 | 21 | $31,500 | $4,757 | 15.1% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 76 | 81 | $44,550 | $4,628 | 10.4% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 32 | 48 | $55,705 | $4,479 | 8.0% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 22 | 23 | $44,810 | $4,243 | 9.5% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 14 | 24 | $16,300 | $4,180 | 25.6% |
| 62321 | Injection of substance into middle or upper spine canal using imaging guidance | Office | 2023 | 15 | 17 | $25,500 | $3,901 | 15.3% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Facility | 2023 | 21 | 35 | $41,850 | $3,786 | 9.0% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 53 | 57 | $79,260 | $3,694 | 4.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 40 | 40 | $8,470 | $3,415 | 40.3% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 60 | 72 | $10,250 | $3,233 | 31.5% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 12 | 14 | $21,000 | $3,146 | 15.0% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2023 | 47 | 78 | $15,365 | $2,998 | 19.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 37 | 52 | $16,970 | $2,952 | 17.4% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 25 | 28 | $28,880 | $2,779 | 9.6% |
| 63685 | Insertion of spinal neurostimulator generator or receiver | Facility | 2023 | 16 | 17 | $75,300 | $2,728 | 3.6% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 11 | 31 | $7,082 | $2,512 | 35.5% |
About Dr. Youssef Josephson, D.O
Dr. Youssef Josephson, D.O is a Physical Medicine & Rehabilitation healthcare provider based in West Deptford, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2008. The National Provider Identifier (NPI) number assigned to this provider is 1598928608.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Youssef Josephson, D.O has received a total of $783,511 in payments from pharmaceutical and medical device companies, with $33,017 received in 2024. These payments were reported across 2,847 transactions from 74 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($477,966).
As a Medicare-enrolled provider, Josephson has provided services to 4,200 Medicare beneficiaries, totaling 7,779 services with total Medicare billing of $640,487. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Other Specialties Pain Medicine, Interventional Pain Medicine
- Location West Deptford, NJ
- Active Since 07/08/2008
- Last Updated 01/07/2025
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1598928608
Products in Payments
- Superion ISS (Device) $173,240
- PROCLAIM (Device) $82,982
- Superion (Device) $62,329
- RESTORE (Device) $53,682
- Neuromodulation Dspsbls and Accs (Device) $41,181
- SYNCHROMED (Device) $36,847
- ADAPTIVESTIM (Device) $33,755
- Prialt (Drug) $33,079
- INTELLIS (Device) $28,914
- VERIFLEX (Device) $25,413
- PAINTEQ (Device) $22,982
- SUPERION (Device) $22,511
- LYRICA (Drug) $19,669
- Nucynta (Drug) $16,335
- OPTIMIZER (Device) $15,005
- Proclaim Family of SCS IPGs (Device) $11,219
- ACTIVOS (Device) $9,073
- RELISTOR (Drug) $8,431
- StimRouter for pain (Device) $6,067
- LUCEMYRA (Drug) $5,661
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.